This is Me Trying | GameChangers

09/22/20 • 23 min

Precision Health and PGx Podcast

Previous Episode

The Power of PGX in the hands of the Pharmacist: Admera Health - PGX for Pharmacists - PPN Episode 763

Dr Sanjeda Chumki, PharmD talks with Ken Sternfeld, host of PGX for Pharmacists about Admera Health and the power of pharmacogenomics in the hands of the clinical pharmacist. About Admera Health: Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health. Dedicated to developing cutting-edge diagnostics that span the continuum of care, Admera Health fulfills unmet medical needs with cost-effective tests and accurate analysis to guide patient care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions. It is our mission to deliver transformative, valuable solutions for patients, physicians, and clinical researchers. We are committed to improving the health and well-being of our global community through the direct delivery of personalized, medically actionable results. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Next Episode

The Next Phase of Pharmacogenomics & the Pharmacist | PGX for Pharmacists

Becky Winslow, PharmD & Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists. 23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing. This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing. Guests: Becky Winslow, BS, PharmD - Medical Affairs Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her "Train the Trainer" certification through NACDS and The University of Pittsburgh School of Pharmacy. Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting. Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute. Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve. Kaitlyn Marshall - PharmD Candidate 2021 See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices